BioMed Central advocates full and transparent reporting. Please ensure that your paper provides the information requested below where applicable. On submitting your paper you will be asked to confirm you have included this information, or give reasons for any instances where it is not made available. You will also be asked to upload this file and it should be cited in the Methods section.
Experimental design and statistics
The following information should be included in the Methods section and inserted in the table below:
Question Answer 1. The exact sample size (n) for each experimental group/condition (as a number, not a range). Include details of a power analysis if done, or any other relevant considerations that determined the choice of sample size. For n < 6, individual data values should be shown rather than summary statistics alone. 2. A description of sample collection that enables the reader to understand whether the samples represent technical or biological replicates, and an explanation of inclusion/exclusion criteria if samples or organisms were excluded from the analysis. 3. How samples/ organisms were allocated to experimental groups and processed, and full details of the randomisation procedure used (if relevant). 4. For sample assessment by human investigators, a statement on whether the investigator was blinded to group assignment and outcome assessment, and how this blinding was achieved and evaluated (if relevant).
Fifty-six mice were randomly divided into seven groups, each group has eight mice on a C57BL/6 background.
Skin thickness was measured using a skin caliper on 12-mm punch biopsy samples obtained from the upper back, away from previous sites of drug injection. A skin caliper was used to measure skinfold (pinch) thickness at the same area of the upper back of the mouse. The measurement of breaking strength of skin was performed by a tensiometer, with a forceps clamped to one side of the 12-mm skin tissue sample and coupled to another forceps clamped to the furthermost extreme of the tissue sample. All the treatments lasted for 4 weeks, then the mice of each group were sacrificed, and skin tissues were harvested, stored at -80℃, to analyze expression levels of target genes and proteins by western blot and RT-qPCR. Skin tissue samples were fixed with 4% paraformaldehyde, and embedded in paraffin, then cutted into 3 um-thick sample sections for hematoxylin/eosin staining. All the 40 rats were involved in the analysis of results.
Histopathological analysis was used to evaluate the pathological changes of skin tissue in a mouse model. We invited two professional pathologists to diagnose skin biopsy. Both of them gave the same diagnostic result in a blinded manner.
5. How many times each experiment shown was replicated and an indication of the extent of variation from experiment to experiment. 6. Information on the statistical methods and measures used. It should be clear whether the tests are one-sided or two-sided, whether there are adjustments for multiple comparisons, whether medians or means are being shown, whether error bars are standard deviations (SD), standard error of mean (SEM) or confidence intervals. 7. A justification for the appropriateness of statistical tests used to assess significance. Do the data meet the assumptions of the tests? Is there an estimate of variation within each group of data, and is the variance similar between groups that are being statistically compared? In addition, information essential to interpreting the data presented should be made available in the figure and table legends. If the study involves health interventions for human participants, please refer to the relevant reporting guidelines from the EQUATOR Network, and the Biosharing Portal for reporting checklists for biological and biomedical research, where applicable.
Research involving humans
If your research involved humans, please confirm you have adhered to the relevant reporting guideline from the EQUATOR Network, and included the completed checklist as an additional file with your submission:
Answer (page and line number inserted/Not applicable for my study) -I have followed the relevant reporting for my study type, and included a populated checklist with my submission -Not applicable for my study Each experimment was replicated for three times.
Results are represented as means ± SD of separate determinations. Data were analyzed by one-way analysis of variance, as appropriate, followed by Bonferroni post hoc test if F achieved P<0.05 and there was no significant variance in homogeneity. All statistical analyses were performed with Graphpad Prism 6.0 Software. P<0.05 was considered to indicate a statistically significant difference.
The data meet the assumptions of the tests. There is an estimate of variation within each group of data and the variance similar between groups are being statistically compared. Data were analyzed by one-way analysis of variance, as appropriate, followed by Bonferroni post hoc test if F achieved P<0.05 and there was no significant variance in homogeneity. There are figure legends in the manuscript.
Resources
A description of all resources used should be included in the Methods section, with enough information to allow them to be uniquely identified. The table below should be completed with confirmation that this was done (i.e. included in the Methods section) or is not applicable. If this has not been completed, but is applicable, you should contact the journal editorial staff before proceeding.
Answer (page and line number inserted/Not applicable for my study)
•Antibodies: report source, catalogue code, characteristics, dilutions and how they were validated for the system under study.
•Cell lines: report source, whether identity has been authenticated and whether tested for mycoplasma contamination. We encourage researchers to check the NCBI database for contamination of cell lines.
•Organisms: report source, species, strain, sex, age, husbandry, inbred and strain characteristics of transgenic and mutant animals.
•Tools (software, databases and services): report standard tool name, provider and version number, if available. For antibodies, model organisms (mice, zebrafish and flies) and tools, authors are strongly encouraged to cite Research Resource Identifiers (RRIDs). To do so, please go to the Resource Identification Portal to search for your research resource and insert the reference text into your Methods section. 
